#United States #Chicago #AI Solutions #Atrial Fibrillation #Volta Medical

Volta Medical Showcases Innovations at HRS 2026

Volta Medical, a health tech pioneer based in France, is making a significant presence at the Heart Rhythm Society (HRS) Annual Meeting 2026 from April 23-26 in Chicago, Illinois. The company is committed to transforming the landscape of care for patients with complex atrial fibrillation (AF) through innovative artificial intelligence (AI) solutions that promise to enhance treatment outcomes.

The conference is set to feature a series of presentations and interactive sessions illustrating the capability of Volta Medical’s technologies in improving the diagnosis and treatment of AF. Notably, the Rhythm Theater session will be moderated by the esteemed Dr. Dhanunjaya Lakkireddy, who serves as the Executive Medical Director of the Kansas City Heart Rhythm Institute. Alongside him will be a panel of internationally recognized leaders in electrophysiology, sharing valuable insights on how AI-enhanced mapping can significantly assist medical professionals in addressing the complexities of AF.

Presentations and Discussions

Key Sessions at HRS 2026

1. Redefining Complex AF Management
Speaker: Dr. Dhanunjaya Lakkireddy
Date/Time: April 24, 1:30 PM - 2:30 PM CT
Location: Rhythm Theater 2
This session focuses on the integration of AI in simplifying and enhancing AF management specifically for the most challenging patient groups.

2. AI in Cardiac Mapping
Speaker: Dr. Jérôme Kalifa, Chief Medical Officer
Date/Time: April 24, 4:30 PM - 4:40 PM CT
Location: Heart Rhythm Hub 3
This presentation provides a glimpse into the advanced capabilities of AI cardiac mapping technologies that have the potential to transform clinical practice.

3. Using AI to Personalize AF Mapping and Ablation
Speaker: Professor Isabel Deisenhofer
Date/Time: April 26, 8:30 AM - 8:45 AM CT
* Location: Room S103
Insights from the TAILORED-AF study and its implications for personalized mapping and ablation strategies will be highlighted.

Experience the Technology

Visitors to Volta Medical's booth (#1019) at the event will also have the opportunity to explore the Volta AF-Xplorer™ II. This cutting-edge AI solution assists electrophysiologists by identifying and annotating unique abnormalities on intricate 3D maps of the heart. The technology aims to deliver precise information that can significantly enhance the effectiveness of catheter-ablation procedures for persistent AF and other complex arrhythmias.

Atrial Fibrillation: A Growing Concern

Atrial fibrillation, characterized by an irregular heartbeat, poses serious health risks, including increased likelihood of stroke and heart failure. With an estimated 7 million individuals affected in the US alone, the urgency for innovative solutions cannot be overstated. Many patients remain unaware of the serious implications associated with AF, which often leads to untreated conditions that can double the risk of heart-related fatalities. Volta Medical's efforts at HRS 2026 are a vital part of addressing this public health challenge by leveraging the power of AI to improve patient care.

The Mission of Volta Medical

Founded in 2016 by a collaborative group of physicians and a data scientist, Volta Medical aims to advance the treatment of complex cardiac arrhythmias through AI-powered solutions. The company's commitment to enhancing patient outcomes is reflected in its AI for Persistent AF Care program, designed to inform and connect patients, caregivers, and healthcare providers with relevant resources.

Join Volta Medical at HRS 2026 to discover how artificial intelligence is set to reshape the future of cardiac care, especially for individuals facing the challenges of atrial fibrillation. For more information about their initiatives and products, visit www.aiforafib.com.